EPISODE · May 13, 2026 · 2 MIN
Inovio's INO-3112: A Potential Game-Changer for RRP
from The Daily News Now! Business
Inovios Q1 2026 update: INO-3112s FDA approval for RRP, a mid-cycle review with no major issues, and a potential informal meeting for accelerated approval. Docs and patients back HPV-specific therapies, with a new statement from top RRP specialists. Inovio prepares for a self-managed U.S. launch, boosted by a $16M public offering, and has a strong pipeline with new collaborations and cash runway into 2027. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/200234d856df883a
NOW PLAYING
Inovio's INO-3112: A Potential Game-Changer for RRP
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m